Becton Dickinson Revenue 2010-2023 | BDX
Becton Dickinson annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Becton Dickinson revenue for the quarter ending December 31, 2023 was $4.706B, a 2.62% increase year-over-year.
- Becton Dickinson revenue for the twelve months ending December 31, 2023 was $19.492B, a 4.02% increase year-over-year.
- Becton Dickinson annual revenue for 2023 was $19.372B, a 2.66% increase from 2022.
- Becton Dickinson annual revenue for 2022 was $18.87B, a 1.36% decline from 2021.
- Becton Dickinson annual revenue for 2021 was $19.131B, a 19.02% increase from 2020.
Becton Dickinson Annual Revenue
(Millions of US $) |
| 2023 |
$19,372 |
| 2022 |
$18,870 |
| 2021 |
$19,131 |
| 2020 |
$16,074 |
| 2019 |
$17,290 |
| 2018 |
$15,983 |
| 2017 |
$12,093 |
| 2016 |
$12,483 |
| 2015 |
$10,282 |
| 2014 |
$8,446 |
| 2013 |
$8,054 |
| 2012 |
$7,708 |
| 2011 |
$7,584 |
| 2010 |
$7,124 |
| 2009 |
$6,987 |
Becton Dickinson Quarterly Revenue
(Millions of US $) |
| 2023-12-31 |
$4,706 |
| 2023-09-30 |
$5,087 |
| 2023-06-30 |
$4,878 |
| 2023-03-31 |
$4,821 |
| 2022-12-31 |
$4,586 |
| 2022-09-30 |
$4,761 |
| 2022-06-30 |
$4,641 |
| 2022-03-31 |
$4,750 |
| 2021-12-31 |
$4,718 |
| 2021-09-30 |
$4,302 |
| 2021-06-30 |
$4,607 |
| 2021-03-31 |
$4,907 |
| 2020-12-31 |
$5,315 |
| 2020-09-30 |
$3,741 |
| 2020-06-30 |
$3,855 |
| 2020-03-31 |
$4,253 |
| 2019-12-31 |
$4,225 |
| 2019-09-30 |
$4,585 |
| 2019-06-30 |
$4,350 |
| 2019-03-31 |
$4,195 |
| 2018-12-31 |
$4,160 |
| 2018-09-30 |
$4,403 |
| 2018-06-30 |
$4,278 |
| 2018-03-31 |
$4,222 |
| 2017-12-31 |
$3,080 |
| 2017-09-30 |
$3,167 |
| 2017-06-30 |
$3,035 |
| 2017-03-31 |
$2,969 |
| 2016-12-31 |
$2,922 |
| 2016-09-30 |
$3,232 |
| 2016-06-30 |
$3,198 |
| 2016-03-31 |
$3,067 |
| 2015-12-31 |
$2,986 |
| 2015-09-30 |
$3,060 |
| 2015-06-30 |
$3,120 |
| 2015-03-31 |
$2,051 |
| 2014-12-31 |
$2,051 |
| 2014-09-30 |
$2,202 |
| 2014-06-30 |
$2,157 |
| 2014-03-31 |
$2,072 |
| 2013-12-31 |
$2,015 |
| 2013-09-30 |
$2,101 |
| 2013-06-30 |
$2,053 |
| 2013-03-31 |
$2,000 |
| 2012-12-31 |
$1,900 |
| 2012-09-30 |
$1,967 |
| 2012-06-30 |
$1,981 |
| 2012-03-31 |
$1,929 |
| 2011-12-31 |
$1,832 |
| 2011-09-30 |
$1,868 |
| 2011-06-30 |
$1,952 |
| 2011-03-31 |
$1,922 |
| 2010-12-31 |
$1,842 |
| 2010-09-30 |
$1,625 |
| 2010-06-30 |
$1,831 |
| 2010-03-31 |
$1,799 |
| 2009-12-31 |
$1,869 |
| 2009-09-30 |
$1,724 |
| 2009-06-30 |
$1,820 |
| 2009-03-31 |
$1,725 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$67.941B |
$19.372B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
